BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 26811657)

  • 1. Genomic and epigenomic heterogeneity in molecular subtypes of gastric cancer.
    Lim B; Kim JH; Kim M; Kim SY
    World J Gastroenterol; 2016 Jan; 22(3):1190-201. PubMed ID: 26811657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomics Study of Gastric Cancer and Its Molecular Subtypes.
    Yuen ST; Leung SY
    Adv Exp Med Biol; 2016; 908():419-39. PubMed ID: 27573784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosomal Instability in Gastric Cancer Biology.
    Maleki SS; Röcken C
    Neoplasia; 2017 May; 19(5):412-420. PubMed ID: 28431273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-definition CpG methylation of novel genes in gastric carcinogenesis identified by next-generation sequencing.
    Sepulveda JL; Gutierrez-Pajares JL; Luna A; Yao Y; Tobias JW; Thomas S; Woo Y; Giorgi F; Komissarova EV; Califano A; Wang TC; Sepulveda AR
    Mod Pathol; 2016 Feb; 29(2):182-93. PubMed ID: 26769141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 immunostaining cannot be used to predict TP53 mutations in gastric cancer: results from a large Central European cohort.
    Schoop I; Maleki SS; Behrens HM; Krüger S; Haag J; Röcken C
    Hum Pathol; 2020 Nov; 105():53-66. PubMed ID: 32971129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Classification of Epstein-Barr virus-positive gastric cancers by definition of DNA methylation epigenotypes.
    Matsusaka K; Kaneda A; Nagae G; Ushiku T; Kikuchi Y; Hino R; Uozaki H; Seto Y; Takada K; Aburatani H; Fukayama M
    Cancer Res; 2011 Dec; 71(23):7187-97. PubMed ID: 21990320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New blood markers detection technology: A leap in the diagnosis of gastric cancer.
    Beeharry MK; Liu WT; Yan M; Zhu ZG
    World J Gastroenterol; 2016 Jan; 22(3):1202-12. PubMed ID: 26811658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratumoral Immune Response to Gastric Cancer Varies by Molecular and Histologic Subtype.
    Kim TS; da Silva E; Coit DG; Tang LH
    Am J Surg Pathol; 2019 Jun; 43(6):851-860. PubMed ID: 30969179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment and characterization of cell lines from chromosomal instable colorectal cancer.
    Maletzki C; Gock M; Randow M; Klar E; Huehns M; Prall F; Linnebacher M
    World J Gastroenterol; 2015 Jan; 21(1):164-76. PubMed ID: 25574089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular classification of gastric cancer.
    Röcken C
    Expert Rev Mol Diagn; 2017 Mar; 17(3):293-301. PubMed ID: 28118758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr Virus-Associated Gastric Carcinoma: Use of Host Cell Machineries and Somatic Gene Mutations.
    Abe H; Kaneda A; Fukayama M
    Pathobiology; 2015; 82(5):212-23. PubMed ID: 26337667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic assays for Epstein-Barr virus-positive gastric adenocarcinoma.
    Gulley ML
    Exp Mol Med; 2015 Jan; 47(1):e134. PubMed ID: 25613731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in the molecular diagnostics of gastric cancer.
    Kanda M; Kodera Y
    World J Gastroenterol; 2015 Sep; 21(34):9838-52. PubMed ID: 26379391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the genetic basis of gastric cancer: recent advances.
    Tan IB; Ng I; Tai WM; Tan P
    Expert Rev Gastroenterol Hepatol; 2012 Jun; 6(3):335-41. PubMed ID: 22646255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying molecular drivers of gastric cancer through next-generation sequencing.
    Liang H; Kim YH
    Cancer Lett; 2013 Nov; 340(2):241-6. PubMed ID: 23178814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrative identification of Epstein-Barr virus-associated mutations and epigenetic alterations in gastric cancer.
    Liang Q; Yao X; Tang S; Zhang J; Yau TO; Li X; Tang CM; Kang W; Lung RW; Li JW; Chan TF; Xing R; Lu Y; Lo KW; Wong N; To KF; Yu C; Chan FK; Sung JJ; Yu J
    Gastroenterology; 2014 Dec; 147(6):1350-62.e4. PubMed ID: 25173755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation subtypes and large-scale epigenetic alterations in gastric cancer.
    Zouridis H; Deng N; Ivanova T; Zhu Y; Wong B; Huang D; Wu YH; Wu Y; Tan IB; Liem N; Gopalakrishnan V; Luo Q; Wu J; Lee M; Yong WP; Goh LK; Teh BT; Rozen S; Tan P
    Sci Transl Med; 2012 Oct; 4(156):156ra140. PubMed ID: 23076357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic, epigenetic, and clinicopathologic features of gastric carcinomas with the CpG island methylator phenotype and an association with Epstein-Barr virus.
    Kusano M; Toyota M; Suzuki H; Akino K; Aoki F; Fujita M; Hosokawa M; Shinomura Y; Imai K; Tokino T
    Cancer; 2006 Apr; 106(7):1467-79. PubMed ID: 16518809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges of deciphering gastric cancer heterogeneity.
    Hudler P
    World J Gastroenterol; 2015 Oct; 21(37):10510-27. PubMed ID: 26457012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.